The
following outstanding shares of Common Stock equivalents were excluded from the computation of the diluted net loss per share attributable
to Common Stock for the periods in which a net loss is presented because their effect would have been anti-dilutive.
Schedule
of common stock equivalents were excluded from computation of diluted net loss per share
| | |
2026 | | |
2025 | |
| | |
June 30, | |
| | |
2026 | | |
2025 | |
| Stock options | |
| 4,322,670 | | |
| 4,240,170 | |
| Common Stock warrants | |
| 2,814,057 | | |
| 2,814,057 | |
| Totals | |
| 7,136,727 | | |
| 7,054,227 | |
| Common Stock equivalents were excluded from the computation of the diluted net loss per share | |
| 7,136,727 | | |
| 7,054,227 | |
|